Min Feng

1.1k total citations
31 papers, 803 citations indexed

About

Min Feng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Min Feng has authored 31 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Min Feng's work include Nanoplatforms for cancer theranostics (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Peptidase Inhibition and Analysis (3 papers). Min Feng is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Peptidase Inhibition and Analysis (3 papers). Min Feng collaborates with scholars based in China and United States. Min Feng's co-authors include Wenxian Guan, Song Liu, Wenxian Guan, Jun Feng, Peng-Fei Yan, Hongyang Zhao, Fangcheng Zhang, Feng Sun, Jie Ding and Jie Zhang and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and International Journal of Cancer.

In The Last Decade

Min Feng

28 papers receiving 797 citations

Peers

Min Feng

ONCOL

IMMUN

EPIDE

Zhan Zhang China

Tatsuo Iiyama Japan

Tongyu Zhu China

Michihiro Tanikawa Japan

Angela Kueck United States

Suguru Kadomoto Japan

Xiaogang Li China

Yingying Huang China

Arianna Marino Italy

Zhan Zhang China

Min Feng

331 ×1.3

370 ×1.5

ONCOL

190 ×1.1

IMMUN

149 ×1.1

54 ×0.4

EPIDE

Citations per year, relative to Min Feng Min Feng (= 1×) peers Zhan Zhang

Countries citing papers authored by Min Feng

Since Specialization

Citations

This map shows the geographic impact of Min Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Feng more than expected).

Fields of papers citing papers by Min Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Feng. The network helps show where Min Feng may publish in the future.

Co-authorship network of co-authors of Min Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Min Feng. A scholar is included among the top collaborators of Min Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Feng. Min Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feng, Min, et al.. (2025). Numerical investigation on jet-enhancement effect and interaction of out-of-phase cavitation bubbles excited by thermal nucleation. Ultrasonics Sonochemistry. 118. 107365–107365. 1 indexed citations

Yang, Shuyang, et al.. (2025). Image-guided therapy of colorectal cancer using a zirconium coordinated nanosensitizer. Journal of Nanobiotechnology. 23(1). 732–732.

Liang, Hao, Qunying Yang, Dan Li, et al.. (2025). IL-1β+ tumor-associated macrophages accelerate glioblastoma progression by amplifying the PGE2-EP4 signaling. Journal of Neuroinflammation. 22(1). 233–233.

Xu, Yating, Yi‐Feng Zhao, Yuke Zhang, et al.. (2024). Proton-controlled Dzyaloshinskii–Moriya interaction and topological Hall effect in hydrogenated strontium ruthenate. Materials Horizons. 12(5). 1619–1628.

Jiao, Xiaodan, Xiaoyang Li, Yan Du, et al.. (2024). Positron emission tomography guided synergistic treatment of melanoma using multifunctional zirconium-hematoporphyrin nanosonosensitizers. Journal of Controlled Release. 370. 95–109. 5 indexed citations

Li, Zijian, Min Feng, Jie Zhang, et al.. (2021). WD40 repeat 43 mediates cell survival, proliferation, migration and invasion via vimentin in colorectal cancer. Cancer Cell International. 21(1). 418–418. 12 indexed citations

Zhu, Meilin, Min Feng, Fei He, et al.. (2018). Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer. Clinica Chimica Acta. 483. 296–302. 69 indexed citations

Feng, Min, et al.. (2018). Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution. International Journal of Biological Sciences. 14(9). 1033–1040. 81 indexed citations

Xu, He N., Min Feng, Kavindra Nath, et al.. (2018). Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts. Molecular Imaging and Biology. 21(3). 426–435. 17 indexed citations

10.

Zhuansun, Yongxun, Fengting Huang, Min Feng, et al.. (2017). Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis. OncoTargets and Therapy. Volume 10. 5005–5012. 37 indexed citations

11.

Zhao, Wenxiu, et al.. (2017). High expression of Rap2A is associated with poor prognosis of patients with hepatocellular carcinoma.. PubMed. 10(9). 9607–9613. 11 indexed citations

12.

Sun, Feng, Min Feng, & Wenxian Guan. (2017). Mechanisms of peritoneal dissemination in gastric cancer (Review). Oncology Letters. 14(6). 6991–6998. 50 indexed citations

13.

Feng, Jun, et al.. (2016). Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway. BioMed Research International. 2016. 1–11. 45 indexed citations

14.

Feng, Jun, et al.. (2015). SIRT6 suppresses glioma cell growth via induction of apoptosis, inhibition of oxidative stress and suppression of JAK2/STAT3 signaling pathway activation. Oncology Reports. 35(3). 1395–1402. 57 indexed citations

15.

Feng, Min, et al.. (2014). Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells. Cellular Immunology. 287(2). 100–105. 22 indexed citations

16.

Xu, He N., et al.. (2013). REDOX IMAGING OF THE p53-DEPENDENT MITOCHONDRIAL REDOX STATE IN COLON CANCEREX VIVO. Journal of Innovative Optical Health Sciences. 6(3). 1350016–1350016. 17 indexed citations

17.

Rao, Jianhua, Min Feng, Xiaofeng Qian, et al.. (2013). Liver transplantation treating the patient with hepatic failure associated with sorafenib treatment: report of a case.. PubMed. 60(126). 1317–9. 4 indexed citations

18.

Feng, Min, et al.. (2012). IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion. International Immunopharmacology. 13(2). 135–140. 38 indexed citations

19.

Wang, Zhaojing, et al.. (2012). Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF‐beta signal. Journal of Surgical Oncology. 107(4). 422–427. 31 indexed citations

20.

Feng, Min, et al.. (2008). Determination of TAP1 and TAP2 polymorphism in the Chinese Han population by real‐time TaqMan polymerase chain reaction. Tissue Antigens. 72(5). 441–447. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact